Published on in Vol 23, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23294, first published .
Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers

Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers

Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers

Journals

  1. Fadahunsi K, Wark P, Mastellos N, Gallagher J, Majeed A, Car J. Clinical information quality of digital health technologies: protocol for an international eDelphi study. BMJ Open 2022;12(4):e057430 View
  2. Addo J, Pearce D, Metcalf M, Lundquist C, Thomas G, Barros-Aguirre D, Koh G, Strange M. Living with tuberculosis: a qualitative study of patients’ experiences with disease and treatment. BMC Public Health 2022;22(1) View
  3. Vaz C, Jose N, Tom J, Goodman G, Lee J, Padappayil R, Madathil M, O’Cleirigh C, Rodrigues R, Chai P. Formative acceptance of ingestible biosensors to measure adherence to TB medications. BMC Infectious Diseases 2022;22(1) View
  4. Fahrni M, Saman K, Alkhoshaiban A, Naimat F, Ramzan F, Isa K. Patient-reported outcome measures to detect intentional, mixed, or unintentional non-adherence to medication: a systematic review. BMJ Open 2022;12(9):e057868 View
  5. Manyazewal T, Woldeamanuel Y, Getinet T, Hoover A, Bobosha K, Fuad O, Getahun B, Fekadu A, Holland D, Marconi V. Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial. eClinicalMedicine 2023;56:101820 View
  6. Stadler J. Surveillance, Discipline and Care. Journal of Legal Anthropology 2021;5(1):58 View
  7. Saha S, Saxena D, Raval D, Halkarni N, Doshi R, Joshi M, Sridharan M, Sathwara J, Yasobant S, Shah H, Quazi Z, Rajsekar K, Chowdhury J. Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD): Toward improving the adherence of the patients with drug-sensitive tuberculosis in Nashik, Maharashtra. Frontiers in Public Health 2022;10 View
  8. Garcia-Cremades M, Solans B, Strydom N, Vrijens B, Pillai G, Shaffer C, Thomas B, Savic R. Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment. Annual Review of Pharmacology and Toxicology 2022;62(1):197 View
  9. Mukora R, Maraba N, Orrell C, Jennings L, Naidoo P, Mbatha M, Velen K, Fielding K, Charalambous S, Chetty-Makkan C. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa. BMJ Open 2023;13(3):e065202 View
  10. Shannon E, Mueller S, Schnipper J. Patient, Caregiver, and Clinician Experience with a Technologically Enabled Pillbox: A Qualitative Study. ACI Open 2023;07(02):e61 View
  11. Bala S, Aravind B, Kadas S, Pandve H, Shukla S, Rajesham A, Arnipalli H. Usability of medication event reminder monitoring system and other determinants to improve the adherence to anti-tuberculosis drugs among patients of tertiary care hospital, Hyderabad. BLDE University Journal of Health Sciences 2023;8(1):42 View
  12. Rodrigues R, Varghese S, Mahrous M, Ananthaneni Kumar A, Ahmed M, D'Souza G. Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study. BMJ Open 2023;13(5):e065878 View
  13. Li W, Su M, Zhang W, Fan X, Li R, Gao Y, Wei X. Barriers and facilitators of implementing electronic monitors to improve adherence and health outcomes in tuberculosis patients: protocol for a systematic review based on the Consolidated Framework for Implementation Research. Health Research Policy and Systems 2023;21(1) View
  14. Mukora R, Ahumah B, Maraba N, Orrell C, Jennings L, Naidoo P, Fielding K, Velen K, Charalambous S, Chetty-Makkan C, Shewade H. Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa. PLOS Global Public Health 2023;3(10):e0001885 View
  15. Anenmose Maro R, Mtenga A, Mtesha B, Wilhelm K, Lekashingo N, Sumari-de Boer M, Ngowi K. Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2024;34:100409 View
  16. Chidambaram S, Jain B, Jain U, Mwavu R, Baru R, Thomas B, Greaves F, Jayakumar S, Jain P, Rojo M, Battaglino M, Meara J, Sounderajah V, Celi L, Darzi A, Kalla M. An introduction to digital determinants of health. PLOS Digital Health 2024;3(1):e0000346 View
  17. Tadesse A, Mganga A, Dube T, Alacapa J, van Kalmthout K, Letta T, Mleoh L, Garfin A, Maraba N, Charalambous S, Foster N, Jerene D, Fielding K. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants – A multicountry study. Frontiers in Public Health 2024;12 View
  18. Leung C, Alacapa J, Tasca B, Villanueva A, Masulit S, Ignacio M, Uy K, Pell C, van Kalmthout K, Powers R, Fielding K, Jerene D. Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines: Qualitative Interview Study. JMIR Human Factors 2024;11:e54117 View
  19. Mtenga A, Maro R, Dillip A, Msoka P, Emmanuel N, Ngowi K, Sumari-de Boer M. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study. Online Journal of Public Health Informatics 2024;16:e51662 View
  20. Zary M, Mohamed M, Kafie C, Chilala C, Bahukudumbi S, Foster N, Gore G, Fielding K, Subbaraman R, Schwartzman K. The performance of digital technologies for measuring tuberculosis medication adherence: a systematic review. BMJ Global Health 2024;9(7):e015633 View
  21. Gonçalves Tasca B, Mganga A, Leung C, Shilugu L, Pell C, Onjare B, Luvanda N, Mleoh L, de Groot L, van Kalmthout K, Fielding K, Jerene D, Shin S. Factors related to the utilization of digital adherence technologies in tuberculosis care: A qualitative study among adults in DS-TB treatment, health care providers and other key actors in Tanzania. PLOS Global Public Health 2024;4(8):e0002795 View
  22. Izudi J, Bajunirwe F, Cattamanchi A. Protocol for the effectiveness of multimonth refill of antituberculosis drugs (MORAD) on treatment success among people with drug-susceptible tuberculosis in rural eastern Uganda: a non-inferiority randomised trial. BMJ Public Health 2024;2(2):e001136 View
  23. Sodhi R, Vatsyayan V, Panibatla V, Sayyad K, Williams J, Pattery T, Pal A, Ayatollahi H. Impact of a pilot mHealth intervention on treatment outcomes of TB patients seeking care in the private sector using Propensity Scores Matching—Evidence collated from New Delhi, India. PLOS Digital Health 2024;3(9):e0000421 View